All Posts

Medicinal cannabis products that meet the minimum quality standard The Misuse of Drugs (Medicinal Cannabis) Regulations 2019 (the...

Discontinuation:   We are writing to inform you that Sanofi is discontinuing supply of ketoprofen (Oruvail) SR Capsules 200mg.    Key...

There is a (currently free) clinical information AI tool called Open Evidence 1 . It has been developed by the New England Journal of...

Pharmac Decision: Changes to support increased prescription lengths  Please follow this link  to the Pharmac decision regarding changes...

New community medicine notices Chloramphenicol eye drops: Chlorsig is changing to Chlorafast  (Pharmacode: 335142) Chlorsig eye drops are...

Proposal to change funding criteria and supply arrangements for antiretroviral medicines used to treat HIV Pharmac is now consulting...

Coming up in CPD: Unlocking Options: Insulin Use in Type 2 Diabetes Management WEBINAR 14 October: Ryan Paul on the current role of...

Issue 330 - 2 October 2025 Welcome to the fortnightly Health Improvement and Innovation Digest. The Digest has links to key evidence of...

Proposal to change funding criteria and supply arrangements for antiretroviral medicines used to treat HIV Pharmac is now consulting...

We are writing to inform you of that there has been a delay with a recent shipment of Condyline solution 0.5%   Key messages: AFT...

Tender results Kia ora, Please find attached the 29 September 2025 Tender Notification . Ngā mihi,  Stefanie Moir | Tender Analyst Te...

The timeframe for developing Mental Health and Wellbeing Strategy has been extended to ensure alignment with proposed law changes Last...

Pharmac Update: Primary Care Prescribers | 26 September 2025   Below is the latest information on Pharmac consultations, notifications,...

Sunitinib: Brand change  The funded brand of 12.5 mg, 25 mg, and 50 mg sunitinib capsules is changing to Sunitinib Rex (Rex). There is a...

New listing: We are writing to inform you that from 1 October 2025 we are listing mesalazine 400mg tablets, Octasa brand.   This provides...

Making education easy Issue 34 - 2025 Please see the latest Child Health Research Review issue attached.

Proposal to fund medicines for multiple sclerosis, eye conditions, breast cancer and lung cancer Pharmac is seeking feedback on a...

Lemborexant for Insomnia Lemborexant (DAYVIGO) is a dual orexin receptor antagonist (DORA) used to treat insomnia in adults by helping...

Pharmac Update: Primary Care Prescribers | 19 September 2025   Below is the latest information on Pharmac consultations, notifications,...